Unknown

Dataset Information

0

Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial.

ABSTRACT:

SUBMITTER: Wiebe J 

PROVIDER: S-EPMC9743231 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Clinical outcomes of everolimus-eluting bioresorbable scaffolds or everolimus-eluting stents in patients with acute myocardial infarction: two-year results of the randomised ISAR-Absorb MI trial.

Wiebe Jens J   Byrne Robert A RA   Alfonso Fernando F   Maeng Michael M   Bradaric Christian C   Kretov Evgeny E   Cuesta Javier J   Kuna Constantin C   Ibrahim Tareq T   Rivero Fernando F   Heugl Mira M   Christiansen Evald Høj EH   Joner Michael M   Schunkert Heribert H   Laugwitz Karl-Ludwig KL   Kastrati Adnan A   Cassese Salvatore S  

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20220301 16

Similar Datasets

Unknown Optical coherence tomography tissue coverage and characterization at six months after implantation of bioresorbable scaffolds versus conventional everolimus eluting stents in the ISAR-Absorb MI trial.
| S-EPMC8494721 | biostudies-literature
Unknown Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction-TROFI II trial.
| S-EPMC4712350 | biostudies-literature
Unknown Overlapping meta-analyses of bioresorbable vascular scaffolds versus everolimus-eluting stents: bringing clarity or confusion?
| S-EPMC4958870 | biostudies-literature
Unknown Long-term clinical outcomes of everolimus-eluting bioresorbable scaffolds versus everolimus-eluting stents: final five-year results of the AIDA randomised clinical trial.
| S-EPMC9743247 | biostudies-literature
Unknown Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
| S-EPMC9544452 | biostudies-literature
Unknown Bioresorbable scaffolds vs. drug-eluting stents for patients with myocardial infarction: A systematic review and meta-analysis of randomized clinical trials.
| S-EPMC9649707 | biostudies-literature
Unknown Long-term outcomes after treatment of in-stent restenosis using the Absorb everolimus-eluting bioresorbable scaffold.
| S-EPMC8438862 | biostudies-literature
Unknown Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial.
| S-EPMC3926690 | biostudies-literature
Unknown Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice.
| S-EPMC9902667 | biostudies-literature
Unknown One-Month Dual Antiplatelet Therapy After Bioresorbable Polymer Everolimus-Eluting Stents in High Bleeding Risk Patients.
| S-EPMC9075308 | biostudies-literature